Article
PIEZO2 expression is an independent biomarker prognostic for gastric cancer and represents a potential therapeutic target
12 Jan 2024
Abstract excerpt
Gastric cancer (GC) is one of the most prevalent malignant tumors of the gastrointestinal system in the globe. The effect of PIEZO2 on the immune function and pathological features of gastric cancer remains to be explored. The Online database of cancer genes and GSE54129 have been used to analyze the clinical characteristics of PIEZO2 expression. We looked at the relationship between PIEZO2 and the immune systems...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
